Loading...
机构名称:
¥ 5.0

•Horizo​​n-HLTH-2025-01-Disease-01:随机对照试验,用于测试噬菌体治疗的安全性和疗效用于治疗抗生素耐药细菌感染的疗效•Horizo​​n-HLTH-2025-01-DISESE-02:促进精神,行为,行为式和神经模型的创新干预措施: HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody- derived proteins for the prevention and treatment of infectious diseases with epidemic potential • HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response • HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research传染病准备协作(GLOPID-R)•Horizo​​n-HLTH-2025-01-Disease-06:实施研究涉及在非可接触性疾病(GACD)

20241106_EU_COERATIVE RESSIDES

20241106_EU_COERATIVE RESSIDESPDF文件第1页

20241106_EU_COERATIVE RESSIDESPDF文件第2页

20241106_EU_COERATIVE RESSIDESPDF文件第3页

20241106_EU_COERATIVE RESSIDESPDF文件第4页

20241106_EU_COERATIVE RESSIDESPDF文件第5页